Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

192

Full text

154

Free full text

Publication Types

Journal Article

192

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Review

Multicenter Study

Comparative Study

Clinical Trial

Systematic Review

Clinical Trial, Phase III

Meta-Analysis

Research Support, N.I.H., Extramural

Case Reports

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Observational Study

Letter

Evaluation Study

Clinical Trial, Phase I

Network Meta-Analysis

Clinical Trial Protocol

Controlled Clinical Trial

Comment

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase IV

Pragmatic Clinical Trial

Equivalence Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Exenatide""[mesh_terms]

195 Results

Searching titles within these results

The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes.

Ewelina Młynarska, Jacek Rysz, Beata Franczyk, Julia Krzemińska, Magdalena Wronka

International journal of molecular sciences 2022;23(24):

Free Full Text

Abstract

Potential use of exenatide for the treatment of obesity.

Franco Folli, Rodolfo Guardado Mendoza

Expert opinion on investigational drugs 2012;20(12):1717-22

Free Full Text

Abstract

Effects of Exenatide plus Metformin versus Metformin alone on insulin resistance in women with Polycystic Ovary Syndrome: A systematic review and meta-analysis.

Abd-Alrahman Al-Qudah, Mohammad Al-Hanaktah, Reham Albadaineh

The journal of obstetrics and gynaecology research 2025;51(5):e16296

Full Text

Abstract

Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.

Charlotte C van Ruiten, Annemarie B van der Aart-van der Beek, Richard G IJzerman, Max Nieuwdorp, Klaas Hoogenberg, Daniël H van Raalte, Hiddo J L Heerspink

Diabetes, obesity & metabolism 2021;23(8):1851-1858

Free Full Text

Abstract

Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.

Feng Sun, Shanshan Wu, Jing Wang, Shuxia Guo, Sanbao Chai, Zhirong Yang, Lishi Li, Yuan Zhang, Linong Ji, Siyan Zhan

Clinical therapeutics 2016;37(1):225-241.e8

Full Text

Abstract

Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.

Ele Ferrannini, Simona Baldi, Juan P Frías, Cristian Guja, Elise Hardy, Enrico Repetto, Serge A Jabbour, Ralph A DeFronzo

Diabetes, obesity & metabolism 2021;22(1):99-106

Full Text

Abstract

Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations.

Karen L Jones, Lian Q Huynh, Seva Hatzinikolas, Rachael S Rigda, Liza K Phillips, Hung T Pham, Chinmay S Marathe, Tongzhi Wu, Charles H Malbert, Julie E Stevens, Kylie Lange, Christopher K Rayner, Michael Horowitz

Diabetes, obesity & metabolism 2021;22(5):788-797

Full Text

Abstract

Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial.

Claudia K Fox, Justin M Clark, Kyle D Rudser, Justin R Ryder, Amy C Gross, Brandon M Nathan, Muna Sunni, Donald R Dengel, Charles J Billington, Megan O Bensignor, Aaron S Kelly

Obesity (Silver Spring, Md.) 2022;30(5):1105-1115

Free Full Text

Abstract

Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.

Nienke M A Idzerda, Lindsay E Clegg, Adrian F Hernandez, George Bakris, Robert C Penland, David W Boulton, M Angelyn Bethel, Rury R Holman, Hiddo J L Heerspink

Diabetes, obesity & metabolism 2021;22(5):798-806

Free Full Text

Abstract

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.

Charlotte C van Ruiten, Mark M Smits, Megan D Kok, Erik H Serné, Daniël H van Raalte, Mark H H Kramer, Max Nieuwdorp, Richard G IJzerman

Cardiovascular diabetology 2022;21(1):63

Free Full Text

Abstract

Neutral effect of exenatide on serum testosterone in men with type 2 diabetes mellitus: A prospective cohort.

Sky Graybill, Jennifer Hatfield, Maria Kravchenko, Darrick Beckman, Joshua Tate, Alexis Beauvais, Philip Clerc, Desarae Davila, Whitney Forbes, Jana Wardian, Matthew Kemm, Abegail Hubberd, Mark True

Andrology 2021;9(3):792-800

Free Full Text

Abstract

Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist.

Ashley H Shoemaker, Heidi J Silver, Maciej Buchowski, James C Slaughter, Jack A Yanovski, Clinton Elfers, Christian L Roth, M Jennifer Abuzzahab

International journal of obesity (2005) 2022;46(3):623-629

Free Full Text

Abstract

Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus.

Paul L McCormack, Yahiya Y Syed

Drugs 2016;75(10):1141-52

Full Text

Abstract

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.

Amalia Gastaldelli, Enrico Repetto, Cristian Guja, Elise Hardy, Jenny Han, Serge A Jabbour, Ele Ferrannini

Diabetes, obesity & metabolism 2021;22(3):393-403

Free Full Text

Abstract

Is exenatide advancing the treatment of type 2 diabetes?

Sheila A Doggrell

Expert opinion on pharmacotherapy 2006;7(1):109-12

Full Text

Abstract

Results: 1 – 15 / 195

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Exenatide""[mesh_terms]

The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes.

Potential use of exenatide for the treatment of obesity.

Effects of Exenatide plus Metformin versus Metformin alone on insulin resistance in women with Polycystic Ovary Syndrome: A systematic review and meta-analysis.

Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.

Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.

Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.

Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations.

Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial.

Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.

Neutral effect of exenatide on serum testosterone in men with type 2 diabetes mellitus: A prospective cohort.

Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist.

Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus.

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.

Is exenatide advancing the treatment of type 2 diabetes?

Results for
""Exenatide""[mesh_terms]